Category: Biotechnology
The collaboration specifically focuses on the development, discovery and commercialization for potential new drugs. Under the terms of the agreement, Avidity would receive $20 million in upfront payment and a $15 million investment. Eli Lilly and Company (Lilly), a renowned American pharmaceutical company, has reportedly …
The acquisition would be helping Catalent in expanding its capabilities of developing costly & specialized gene therapy treatments. The company would be carrying out the acquisition through an all-cash deal, scheduled to be announced soon. Catalent, Inc., (Catalent), a New Jersey-based technology & pharmaceutical firm, …
The partnership expansion would further support the development of rapid diagnostic assays needed for detecting sepsis Novacyt, a global clinical diagnostics specialist, has recently announced that Primerdesign Ltd, its molecular testing division, has expanded its assay development contract with Immunexpress, Inc., a molecular diagnostic company …
The two firms will focus on accelerating global development of companion tests for several oncology therapies. Renowned precision diagnostics firm, Cellgen Diagnostics has recently announced a strategic collaboration with Genomic Testing Cooperative (GTC) to help accelerate global development of companion tests for various oncology therapeutics. …
More than eight individuals treated with the SB-525 gene therapy demonstrated increases in FVIII activity that was dose-dependent. The FVIII levels reached normal in two patients that were treated with a 3e13 vg/kg dose. Sangamo Therapeutics, Inc., (Sangamo), a California-based biotechnology company, and New York-based …
The new drug is anticipated to be available for its commercial launch in the second half of 2019. ADMA Biologics Inc., has reportedly announced that its IVIG (Intravenous Immune Globulin) drug ASCENIV™ has been approved by the U.S. FDA (Food & Drug Administration). The new …
Biohaven recently announced the expanded data from the Phase IIb/III long-term extension study of troriluzole, with its comparison to coordinated natural history cohort Biohaven Pharmaceutical Holding Company Ltd., a U.S.-based clinical-stage biopharmaceutical company, has made it to the front page with the enrollment of its …
The amount raised in the latest financing round brings the total capital raised by the company within a year to $222 million. Proceeds from the Series B financing round would be going towards the development of its next-gen CRISPR technologies & its array of base …
Adagene Inc., an innovative clinical-stage biotechnology firm, has made it to the front page with the announcement of a multi-target platform evaluation with the American biotechnology company, Celgene Corporation. As per the terms of the agreement, Adagene is expected to deploy its Dynamic Precision Library …